Cargando…
Bone marrow micrometastases in early breast cancer–30-year outcome
BACKGROUND: Micrometastases in bone marrow of women with early breast cancer were first identified immunocytochemically in the 1980s. We report on the original cohort of women with a median follow-up of 30 years. PATIENTS AND METHODS: In total, 350 women with primary breast cancer had eight bone mar...
Autores principales: | Mansi, J, Morden, J, Bliss, J M, Neville, M, Coombes, R C |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4742582/ https://www.ncbi.nlm.nih.gov/pubmed/26766739 http://dx.doi.org/10.1038/bjc.2015.447 |
Ejemplares similares
-
Axillary lymph node micrometastases decrease triple-negative early breast cancer survival
por: Houvenaeghel, G, et al.
Publicado: (2016) -
Enrichment methods to detect bone marrow micrometastases in breast carcinoma patients: clinical relevance
por: Choesmel, Valérie, et al.
Publicado: (2004) -
Bone Marrow Micrometastases in Breast Cancer Patients: A Long-Term Follow-up Study
por: Molino, Annamaria, et al.
Publicado: (2008) -
Immunodetection of bone marrow micrometastases in breast carcinoma patients and its correlation with primary tumour prognostic features.
por: Ménard, S., et al.
Publicado: (1994) -
Bone marrow mammaglobin-1 (SCGB2A2) immunohistochemistry expression as a breast cancer specific marker for early detection of bone marrow micrometastases
por: Talaat, Iman Mamdouh, et al.
Publicado: (2020)